ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 007

Single Cell RNA Sequencing Analysis of the Skin to Evaluate the Effect of Autologous Stem Cell Transplant on Fibroblast Populations in Juvenile Onset Systemic Sclerosis

Claire Cheng, Giffin Werner, Anwesha Sanyal and Kathryn Torok, University of Pittsburgh, Pittsburgh, PA

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Fibroblasts, Dermal, Pediatric rheumatology, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, April 1, 2023

Title: Plenary Abstracts Session III

Session Type: Plenary Session

Session Time: 11:00AM-12:00PM

Background/Purpose: Juvenile systemic sclerosis (JSSc) is a rare autoimmune disease associated with high morbidity. Inflammatory driven multi-organ fibrosis is similar to adult-onset SSc, with 40% of JSSc patients recently identified in an international cohort to have interstitial lung disease. There are a group of JSSc patients that have severe, refractory disease to standard immunosuppression regimens. For these patients, autologous stem cell therapy (ASCT) provides a possibility to reset the immune system and provide clinical benefit with much lower transplant-related mortality. Our center reported the clinical improvement of the first 3 JSSc patients with a CD-34 selected ASCT protocol at the American College of Rheumatology 2021 Convergence (Abstract 0778). The current abstract describes the single-cell RNA sequencing (scRNA-seq) profile of these 3 JSSc patients skin at baseline (pre-ASCT), 6-mos and 12-mos post-ASCT to define the shift in fibroblast populations and transcriptome expression.

Methods: scRNA-seq was performed on the skin of 3 JSSc patients at the baseline, 6-mos and 12-mos post-ASCT, along with 3 healthy aged-matched controls. Library preparation with a 10X Genomics® Chromium instrument and sequencing on Illumina NextSeq instrument was performed. Transcripts were mapped to reference human genome GRCh38 and assigned to cells of origin using the Cell Ranger pipeline (10X Genomics®). R-language analyses using Seurat and Harmony identified and visualized distinct cell populations by clustering methodologies.

Results: JSSc and healthy control fibroblasts clustered into 13 unique subclusters (Fig 1a). One fibroblast subcluster, defined by COCH/CRABP1(3) expression, increased after ASCT and at 12-mos post-ASCT it matched the frequency found in healthy controls (Fig 1b). Two fibroblast subpopulations, defined by COL11A1/ACTA2 (6) and SFRP2/COL6 (9) expression, decreased by half after ASCT, both mirroring healthy control frequency by 12 mos post-ASCT. In addition to the shift of these fibroblast subclusters towards a healthy distribution after ASCT, differential expression of gene (DEG) analyses found significant changes in pro-fibrotic genes: WIF1, DPEP1, and FBLN2, with decreased expression after ASCT (Figure 2a), and changes in wound-healing genes: POSTN, TNC, and IGFBP4, with increased expression after ASCT (Figure 2b). All 3 patients experienced dramatic improvement in skin score and other global outcome measures by 6 mos and sustained this at 12 mos (data not shown here; ACR 2021 Abstract 0778).

Conclusion: Dynamic changes were noted in JSSc fibroblast subclusters, overall shifting toward a healthy skin fibroblast distribution by 12-mos post-ASCT. The COL11A1/ACTA2 cluster represents contractile follicle-related cells containing myofibroblasts, and the SFRP2/COL6 cluster represent reticular and papillary dermal cells, both decreasing after ASCT and possibly pathogenic, and will be further studied. DEG analysis showed an upregulation of wound-healing associated genes: POSTN, TNC, and a downregulation of fibrosis-related genes: WIF1, DPEP1, and FBLN2, reflecting shift in fibroblast phenotype toward decreased fibrosis and increased elasticity.

Supporting image 1Figure 1 a & b: (a) tSNE analysis of fibroblast transcriptomes (total fibroblast cell count = 6216) from 3 JSSc patients and 3 healthy controls. (b) Relative cell proportion difference per fibroblast subcluster compared between healthy controls to baseline, 6-months and 12-months post-ASCT in JSSc.

Supporting image 2Figure 2a: Feature plots of fibroblasts demonstrating increased gene expression of POSTN, TNC and IGFB4 in JSSc after ASCT with matching expression to healthy controls at 12-months post-ASCT. Supporting wound healing genes increased expression.

Supporting image 3Figure 2b: Decreased fibrotic genes, WIFI, DPEP1 and FBLN2, across fibroblast populations after ASCT, with expression decreased to level of healthy controls at 12 months post-ASCT. Reflecting decreased fibrotic signal, and mirroring decreased skin thickness.


Disclosures: C. Cheng: None; G. Werner: None; A. Sanyal: None; K. Torok: None.

To cite this abstract in AMA style:

Cheng C, Werner G, Sanyal A, Torok K. Single Cell RNA Sequencing Analysis of the Skin to Evaluate the Effect of Autologous Stem Cell Transplant on Fibroblast Populations in Juvenile Onset Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/single-cell-rna-sequencing-analysis-of-the-skin-to-evaluate-the-effect-of-autologous-stem-cell-transplant-on-fibroblast-populations-in-juvenile-onset-systemic-sclerosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-sequencing-analysis-of-the-skin-to-evaluate-the-effect-of-autologous-stem-cell-transplant-on-fibroblast-populations-in-juvenile-onset-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology